New Leg Stent Gets Ellen Back in the Race

EMBED </>More Videos

With a new approach to leg stents, some patients not only walk again, they can run. (KFSN)

One in every 20 Americans over the age of 50 experiences peripheral artery disease, clogged arteries, usually in the legs, which can cause extreme pain and increase the risk for heart attack and stroke. Now, with a new approach to leg stents, some patients not only walk again, they can run.

Seventy-three-year old Ellen Bergami is running competitively again, but a year ago she experienced so much pain in her leg that she was facing amputation.

"I cannot tell you how much pain you are in cause it's like a tourniquet on your leg shutting down and you're getting no blood," detailed Bergami.

Bergami was experiencing an acute form of peripheral artery disease that was shutting down the blood flow to her right leg. After a series of failed procedures, she was still in constant pain and addicted to fentanyl.

Mirza Baig, M.D., a vascular surgeon at Baylor Scott & White Medical Center in Irving, Texas, told Ivanhoe, "I think that she was at a point where she had so much pain in her foot that I think if she wanted, or required an amputation, she would have been relieved." (Read Full Interview)

Doctors replaced Bergami's old metal stents with fabric stents. Drug-coated balloons at the ends keep the femoral artery open. These new stents have lasted more than a year and a half and changed Bergami's life.

Dr. Baig said, "I think drug-coated balloons are going to turn out to be a medical breakthrough. I think that the data so far is pretty good."

Recently, Bergami ran a 5K and finished third in her age group.

"My medal is from November 2016 and it is an honor to wear it and to put it on to know that I did it."

The drug-coated balloons, approved by the FDA in 2015, are showing good outcomes and reducing the need for repeat procedures.

For more information on this report, please contact:

Susan Hall


Related Topics:
healthsurgeryhealth watch
(Copyright ©2018 KFSN-TV. All Rights Reserved.)